AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 74 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,000 | – | 20,066 | +8331.1% | 0.00% | – |
| Q1 2024 | $0 | – | 238 | +138.0% | 0.00% | – |
| Q4 2023 | $0 | – | 100 | -80.0% | 0.00% | – |
| Q2 2023 | $0 | – | 500 | +7.1% | 0.00% | – |
| Q3 2022 | $0 | – | 467 | -20.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 587 | -94.6% | 0.00% | – |
| Q1 2022 | $8,000 | -90.0% | 10,837 | -69.7% | 0.00% | – |
| Q4 2021 | $80,000 | +81.8% | 35,795 | +135.3% | 0.00% | – |
| Q3 2021 | $44,000 | -2.2% | 15,211 | +26.8% | 0.00% | – |
| Q2 2021 | $45,000 | -6.2% | 11,992 | -14.0% | 0.00% | – |
| Q1 2021 | $48,000 | -77.0% | 13,943 | -81.3% | 0.00% | – |
| Q4 2020 | $209,000 | +1206.2% | 74,688 | +1086.7% | 0.00% | – |
| Q3 2020 | $16,000 | -23.8% | 6,294 | +309.2% | 0.00% | – |
| Q2 2020 | $21,000 | +50.0% | 1,538 | -15.2% | 0.00% | – |
| Q1 2020 | $14,000 | -73.1% | 1,814 | -78.2% | 0.00% | – |
| Q4 2019 | $52,000 | +940.0% | 8,307 | +534.1% | 0.00% | – |
| Q3 2019 | $5,000 | -50.0% | 1,310 | -39.8% | 0.00% | – |
| Q2 2019 | $10,000 | -16.7% | 2,176 | +39.0% | 0.00% | – |
| Q1 2019 | $12,000 | +50.0% | 1,566 | 0.0% | 0.00% | – |
| Q4 2018 | $8,000 | -52.9% | 1,566 | -17.0% | 0.00% | – |
| Q3 2018 | $17,000 | +88.9% | 1,887 | +119.4% | 0.00% | – |
| Q2 2018 | $9,000 | +350.0% | 860 | +628.8% | 0.00% | – |
| Q1 2018 | $2,000 | -77.8% | 118 | -79.2% | 0.00% | – |
| Q4 2017 | $9,000 | -90.2% | 568 | -87.8% | 0.00% | – |
| Q3 2017 | $92,000 | +820.0% | 4,652 | +501.0% | 0.00% | – |
| Q2 2017 | $10,000 | -52.4% | 774 | -66.8% | 0.00% | – |
| Q1 2017 | $21,000 | -85.0% | 2,331 | -82.6% | 0.00% | – |
| Q4 2016 | $140,000 | +20.7% | 13,389 | +4.6% | 0.00% | – |
| Q3 2016 | $116,000 | +20.8% | 12,800 | 0.0% | 0.00% | – |
| Q2 2016 | $96,000 | +190.9% | 12,800 | +250.1% | 0.00% | – |
| Q1 2016 | $33,000 | -87.2% | 3,656 | -81.7% | 0.00% | – |
| Q4 2015 | $258,000 | +116.8% | 19,986 | +61.5% | 0.00% | – |
| Q3 2015 | $119,000 | -54.2% | 12,378 | -51.0% | 0.00% | – |
| Q2 2015 | $260,000 | +11.1% | 25,258 | +20.2% | 0.00% | – |
| Q1 2015 | $234,000 | +875.0% | 21,012 | +900.6% | 0.00% | – |
| Q4 2014 | $24,000 | -14.3% | 2,100 | +68.0% | 0.00% | – |
| Q3 2014 | $28,000 | -95.2% | 1,250 | -94.0% | 0.00% | – |
| Q2 2014 | $582,000 | – | 20,950 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,121,283 | $53,979,000 | 4.02% |
| DAFNA Capital Management LLC | 853,538 | $6,470,000 | 2.70% |
| Baupost Group | 17,527,968 | $132,862,000 | 1.96% |
| Nantahala Capital Management | 6,559,478 | $49,721,000 | 1.86% |
| Novo Holdings A/S | 3,393,039 | $25,719,000 | 1.72% |
| Abrams Capital Management | 5,656,462 | $42,876,000 | 1.69% |
| Stanley-Laman Group, Ltd. | 319,073 | $2,419,000 | 0.73% |
| Integral Health Asset Management, LLC | 200,000 | $1,516,000 | 0.67% |
| KNOTT DAVID M | 135,169 | $1,025,000 | 0.65% |
| Leap Investments LP | 54,700 | $415,000 | 0.61% |